37 results found.

Kidney Transplantation, or GI Symptoms Severity Clinical Trial

Novartis - Recruiting 18 years or older.
- Open, Multi-centre, Non-interventional, Observational Study to Characterize the Impact That GI Complaints Have on Patient-reported Outcomes in Patients Who Have Had a Renal Transplant. Patients Will be Evaluated at Visit 1 and Then Again After 4 (+2) Weeks (Visit 2).

Kidney Transplantation Recipients Clinical Trial

Asan Medical Center - Recruiting 16 years to 90 years.
- Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Kidney Transplant Recipients (ACE-KT).

Kidney Transplantation Clinical Trial

Asan Medical Center - Recruiting 16 years or older.
- Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT).

Renal Function, or Liver Transplantation Clinical Trial using living donor liver transplantation

Samsung Medical Center - Recruiting 20 years to 70 years.
- Incidence, Risk Factors, and Risk Model of Acute Kidney Injury After Liver Transplantation.
living donor liver transplantation

Heart Transplantation, Kidney Transplantation, Liver Transplantat Clinical Trial

Genentech - Recruiting N/A or older.
- The Mycophenolate Pregnancy Registry.

Kidney Transplantation Clinical Trial using Belatacept

East Carolina University - Recruiting 18 years to 75 years.
- An Exploratory, Open-label, Single Center Study to Assess the Efficacy of NULOJIX (Belatacept) in Reducing Donor Specific HLA Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients.
Belatacept

Deceased Donor Kidney Transplantation, or Living Donor Kidney Tra Clinical Trial using kidney transplantation, living or deceased donor

Samsung Medical Center - Recruiting N/A or older.
- Adequate Definition of Delayed Graft Function in Living and Deceased Donor Kidney Transplantation.
kidney transplantation, living or deceased donor

Secondary Hyperparathyroidism Due to Renal Causes Clinical Trial using Paricalcitol; Calcifediol

Fundaci¢n Senefro - Recruiting 18 years or older.
- Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Renal Transplantation..
Paricalcitol; Calcifediol

Renal Transplant Candidate for Right Kidney, or Renal Transplant Clinical Trial

University of Aarhus - Recruiting 18 years or older.
- Angiographic CT of Renal Transplantation Candidate - Study.

Kidney Disease, Kidney Transplantation, or Kidney Failure, Chroni Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Role of Donor Genetics and Recipient Genetics in Kidney Transplant Outcomes.

Renal Cell Carcinoma, Graft-Versus-Host Disease, or Engraftment S Clinical Trial using Pentostatin; Sirolimus; Cyclophosphamide; Allogeneic Hematopoietic Stem Cell Transplant; Th2 Cell Transplantation; Th2 Cells in Allogeneic HSCT

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 75 years.
- Low Intensity Allogeneic Hematopoietic Stem Cell Transplantation Therapy of Metastatic Renal Cell Carcinoma Using Early and Multiple Donor Lymphocyte Infusions Consisting of Sirolimus-Generated Donor Th2 Cells.
Pentostatin; Sirolimus; Cyclophosphamide; Allogeneic Hematopoietic Stem Cell Transplant; Th2 Cell Transplantation; Th2 Cells in Allogeneic HSCT

Acute Kidney Injury Clinical Trial

Universitaire Ziekenhuizen Leuven - Recruiting 18 years or older.
- The Role of Biomarkers in the Early Detection of Acute Kidney Injury Induced by Liver Transplantation : an Observational Analysis..

Kidney Transplant Clinical Trial using Tacrolimus + MMF + Prednisone, followed by Tacrolimus Withdrawal; MMF/Tacrolimus/Prednisone

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years or older.
- Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation.
Tacrolimus + MMF + Prednisone, followed by Tacrolimus Withdrawal; MMF/Tacrolimus/Prednisone

Kidney Transplantation Clinical Trial using Cyclosporine; CP-690,550

Pfizer - Recruiting 18 years to 70 years.
- A Phase 2, Multicenter, Open-Label, Active Comparator-Controlled, Extension Trial To Evaluate The Long-Term Safety And Efficacy Of CP-690,550 In Renal Allograft Recipients.
Cyclosporine; CP-690,550

Unspecified Complications of Kidney Transplant, or Disorder Relat Clinical Trial using Workbook

Northwestern University - Recruiting 18 years to 85 years.
- Evaluation of Sun Protection Education for Kidney Transplant Recipients.
Workbook

Kidney Transplantation Clinical Trial using Tacrolimus; CP-690,550

Pfizer - Recruiting 18 years to 70 years.
- A Multicenter, Phase 2, Open-Label, Controlled, Extension Study For Stage 1 Subjects Of Study A3921009 To Evaluate The Long-Term Safety And Efficacy Of CP-690,550 Versus Tacrolimus, When Co-Administered With Mycophenolate Mofetil In Renal Allograft Recipients.
Tacrolimus; CP-690,550

Kidney Transplantation, Renal Transplantation Clinical Trial using RAD001; Tacrolimus; Cyclosporin A; Enteric Coated Mycophenolate Sodium (EC-MPS) or Mycophenolate Mofetil (MMF); Corticosteroids

Novartis - Recruiting 18 years or older.
- 12 Month, Multi-center, Open-label, Prospective, Randomized, Parallel Group Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Certicanr Based Regimen Either in Combination With Cyclosporin A or Tacrolimus.
RAD001; Tacrolimus; Cyclosporin A; Enteric Coated Mycophenolate Sodium (EC-MPS) or Mycophenolate Mofetil (MMF); Corticosteroids

Liver Transplantation, or Kidney Transplantation Clinical Trial using rTPA Treatment

The Cleveland Clinic - Recruiting 18 years or older.
- Enhancing DCD Utilization With Thrombolytic Therapy.
rTPA Treatment

Kidney Transplantation Clinical Trial using Everolimus; Sirolimus

University of Colorado, Denver - Recruiting 18 years to 70 years.
- Differentiating Sirolimus and Everolimus in Combination With Calcineurin Inhibitors in Long-term Maintenance of Kidney Transplant Patients - The Effects on Vascular Endothelial and Kidney Function. The DESIRE Study..
Everolimus; Sirolimus

Chronic Kidney Disease, Acute Myeloid Leukemia (AML), Acute Lymph Clinical Trial using Haploidentical Bone Marrow/Kidney

Massachusetts General Hospital - Recruiting 18 years to 70 years.
- Combined Haploidentical Reduced Intensity Bone Marrow and Kidney Transplantation for Patients With Chronic Kidney Disease and Advanced Hematological Disorders.
Haploidentical Bone Marrow/Kidney

Kidney; Complications, Allograft Clinical Trial using eculizumab

Yale University - Recruiting 18 years to 65 years.
- Eculizumab Therapy for Chronic Complement-Mediated Injury in Kidney Transplantation: A Randomized, Open-Label, Pilot Intervention Trial.
eculizumab

Kidney Transplantation Clinical Trial using Hematopoietic Stem Cell Transplant/novel platform technology

University of Louisville - Recruiting 18 years to 65 years.
- Delayed Tolerance in Recipients of Living Kidney Allografts by Donor Stem Cell Infusion.
Hematopoietic Stem Cell Transplant/novel platform technology

HBsAg(+) Donor Kidney Allograft, or HBsAg(-) Donor Kidney Allogra Clinical Trial using HBsAg positive kidney allograft donor

Chulalongkorn University - Recruiting 18 years to 65 years.
- The Outcomes of Kidney Transplantation Between Recipients Receiving Graft From Donors With Positive and Negative HBsAg.
HBsAg positive kidney allograft donor

Kidney Transplantation Clinical Trial

Hoffmann-La Roche - Recruiting 18 years or older.
- Prospective, Open-label, Non-interventional Study for the Follow-up of Renal Function in de Novo Kidney Transplant Patients Treated With Immunosuppressive Therapy Containing CellCept in Routine Clinical Practice (ORANGE Study).

The Rate of Kidney Transplants in Sensitized Patients Clinical Trial

BiologicTx, LLC - Recruiting 18 years or older.
- Prospective, Multicenter, Observational Registry Study to Determine if Enrollment in a Regional Kidney Paired Donor Exchange Program Improves the Overall Rate of Kidney Transplantation in Sensitized Patients, and Sensitized Patients Undergoing Desensitization Treatments..

Kidney; Complications, Allograft Clinical Trial using Everolimus; Tacrolimus; Mycophenolic acid

Seoul St. Mary's Hospital - Recruiting 20 years or older.
- To Evaluate Prevention Effect Of Everolimus and Low-dose Tacrolimus in Comparison With Standard-dose Tacrolimus Therapy With Mycophenolic Acid on the New Onset Diabetes Mellitus After Transplantation in the Renal Allograft Recipients.
Everolimus; Tacrolimus; Mycophenolic acid

Prevention of New Onset Diabetes Among Kidney Transplant Patients Clinical Trial using Insulin treatment for hyperglycemia

University of Michigan - Recruiting 18 years or older.
- A Clinical Trial to Prevent New Onset Diabetes After Transplantation.
Insulin treatment for hyperglycemia

Kidney Transplantation, Liver Transplantation, Heart Transplantat Clinical Trial using Advagraf; Prograf

Astellas Pharma Inc - Recruiting 5 years to 16 years.
- A Phase II, Open-Label, Multi-Center Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From a Prografr Based Immunosuppressive Regimen to a Tacrolimus Prolonged Release, Advagrafr Based Immunosuppressive Regimen, Including a Long-Term Follow-Up.
Advagraf; Prograf

Kidney Transplantation Clinical Trial using Antithymocyte globulin (ATG); Fludarabine; Low dose Pre-transplant cyclophosphamide; Total Body Irradiation; Acetaminophen; Diphenhydramine; Methylprednisolone; Bone Marrow; MESNA; Mycophenolate mofetil (MMF); Prednisone; Filgrastim; High dose post-transplant cyclophosphamide

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 65 years.
- Bone Marrow Transplantation and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance (ITN054ST).
Antithymocyte globulin (ATG); Fludarabine; Low dose Pre-transplant cyclophosphamide; Total Body Irradiation; Acetaminophen; Diphenhydramine; Methylprednisolone; Bone Marrow; MESNA; Mycophenolate mofetil (MMF); Prednisone; Filgrastim; High dose post-transplant cyclophosphamide

Chronic Renal Failure Clinical Trial using Static incubation; Pulsatile perfusion

Hospices Civils de Lyon - Recruiting 18 years to 80 years.
- Interest of Pulsatile Perfusion Preservation on Outcomes in Kidney Transplantation From Expanded Criteria Donors.
Static incubation; Pulsatile perfusion

Kidney Transplantation Clinical Trial using Everolimus

Hospital do Rim e Hipertensao - Recruiting 18 years or older.
- Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors.
Everolimus

Kidney Transplantation, or Liver Transplantation Clinical Trial using Prevenar13; Pneumovax

Helsinki University Central Hospital - Recruiting 18 years to 70 years.
- Immunogenicity of Repeated Dose 13-valent Pneumococcal Conjugate Vaccine Compared to the Existing Recommended Protocol of Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients.
Prevenar13; Pneumovax

Planned Kidney Transplantation Clinical Trial using Everolimus + Low dose CsA +PD; Myfortic+ Standard CsA + PD

Yonsei University - Recruiting 18 years to 65 years.
- .
Everolimus + Low dose CsA +PD; Myfortic+ Standard CsA + PD

Kidney Transplant Clinical Trial using Zostavax (Live attenuated herpes zoster vaccine); Placebo vaccine

University of Alberta - Recruiting 18 years to 65 years.
- Safety and Immunogenicity of Live Attenuated Herpes Zoster Vaccine in Patients Undergoing Living Donor Kidney Transplantations.
Zostavax (Live attenuated herpes zoster vaccine); Placebo vaccine

Kidney Transplantation Clinical Trial using routine dose tacrolimus and myfortic; low dose tacrolimus and myfortic

Asan Medical Center - Recruiting 20 years to 65 years.
- Organ Function Preservation by the Combination Treatment of the optImuM Dose of calcineUrin Inhibitor and Mycophenolate Sodium in Kidney Recipients: OPTIMUM Study.
routine dose tacrolimus and myfortic; low dose tacrolimus and myfortic

Kidney Cancer Clinical Trial using therapeutic allogeneic lymphocytes; cyclophosphamide; cyclosporine; fludarabine phosphate; allogeneic bone marrow transplantation; peripheral blood stem cell transplantation

National Cancer Institute (NCI) - Recruiting 18 years to 65 years.
- Phase II Trial in Intrafamilial Allogeneic Cell Transplant in Patients With Metastatic Kidney Cancer.
therapeutic allogeneic lymphocytes; cyclophosphamide; cyclosporine; fludarabine phosphate; allogeneic bone marrow transplantation; peripheral blood stem cell transplantation

Kidney Diseases Clinical Trial using everolimus and tacrolimus

Hospital Universitario Ramon y Cajal - Recruiting 18 years to 65 years.
- A Pilot Study to Investigate Pharmacokinetic Characteristics of Everolimus in Patients Treated With Tacrolimus-Based Immunosuppression in De Novo Kidney Transplantation.
everolimus and tacrolimus